eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Allergan Ltd
Marlow International, The Parkway, Marlow, Bucks, SL7 1YL, UK
Telephone: +44 (0)1628 494444
Fax: +44 (0)1628 494449
WWW: http://www.allergan.co.uk
Medical Information Direct Line: +44 (0)1628 494026
Medical Information e-mail: UK_MedInfo@Allergan.com
Out of Hours contact: +44 (0)1628 494026

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 29/11/2011
PIL BOTOX 100 Units

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
  • Changes to therapeutic indications
  • Change to date of revision
Updated on 25/10/2011 and displayed until 29/11/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
Updated on 12/08/2010 and displayed until 25/10/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 16/07/2010 and displayed until 12/08/2010
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 09/09/2008 and displayed until 16/07/2010
Reasons for adding or updating:
  • Change of active ingredient
  • Change to information about driving or using machinery
  • Change due to user-testing of patient information
Updated on 07/07/2007 and displayed until 09/09/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 03/07/2007 and displayed until 07/07/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to how to administer the medicine
  • Change to Further Information section
Updated on 17/05/2006 and displayed until 03/07/2007
Reasons for adding or updating:
  • Change to storage instructions
Updated on 24/08/2005 and displayed until 17/05/2006
Reasons for adding or updating:
  • Change of contra-indications
  • Change to warnings or special precautions for use
  • Change to Further Information section
  • Change to date of revision
Updated on 15/07/2003 and displayed until 24/08/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 17/02/2003 and displayed until 15/07/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  botulinum toxin type a